RE:OptionsI just had a dreadful thought. What if the early and heavy grant of options wast to retain people after there was less than stellar results coming out of the phase 1? This would be a hellish scenario for all as we get futther dilution at very low levels. I think the odds of this are low, given the other actions they have taken, but wouldn't write it off given the history of TH.
SABBOBCAT wrote: While I am incredibly frustrated by the deviation in timing and the size of options granted back in late 2021, I do find solace in the fact thiat this occured. This is perhaps the biggest tell that they have something meaningful in the works. Could be oncology or Nash, but they would not rush that through if there was not a high possibility that they would be releacing materially positive information before the end of March.